Lyndra Therapeutics Inc ceases operations due to funding issues, despite strategic investment from Sun Pharma in 2023.

The issue of drug pricing violations has come under scrutiny, with the Parliamentary Standing Committee on Chemicals and ...

UNLOXCYT™ (cosibelimab-ipdl) approved by U.S. FDA as first and only anti-PD-L1 treatment for advanced cutaneous squamous cell ...

Peethaambaran Kunnathoor, Chennai Friday, March 28, 2025, 08:00 Hrs [IST] ...

Sun Pharma Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard ...

Violations highlight growing concerns over the unchecked rise in medicine prices and their impact on affordability ...

With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

Trump had earlier said on March 24 that he will announce tariffs on automobiles, pharmaceuticals and aluminum in the near ...

Parliamentary Panel asks govt to expand scope of NLEM to include more life-saving medicines: Gireesh Babu, New Delhi Monday, March 24, 2025, 08:00 Hrs [IST] The Parliamentary Pane ...

Indian pharma stocks fell for the third consecutive session amid concerns of potential US tariffs on pharmaceutical imports. The Nifty Pharma Index dropped 1.5%, with J B Chemicals & Pharmaceuticals ...

The developer of a nasal spray-mist erectile dysfunction (ED) treatment, LTR Pharma (ASX:LTP) has revealed a new product – ...

The growth of the India generic drugs market is supported by proactive government policies aimed at bolstering the pharmaceutical sector. Initiatives such as the “Make in India” campaign and ...